OTC Markets OTCQB - Delayed Quote USD

BSF Enterprise Plc (BSFAF)

0.0584
0.0000
(0.00%)
As of May 7 at 4:00:00 PM EDT. Market Open.
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Total Revenue
57.8210
57.8210
12.9420
0
0
Cost of Revenue
84.4650
84.4650
71.3240
0
0
Gross Profit
-26.6440
-26.6440
-58.3820
0
0
Operating Expense
1,761.2970
1,761.2970
1,510.1040
751.6990
58.2180
Operating Income
-1,787.9410
-1,787.9410
-1,568.4860
-751.6990
-58.2180
Net Non Operating Interest Income Expense
-9.5650
-9.5650
-11.9630
-2.1460
-0.1070
Pretax Income
-1,797.5060
-1,797.5060
-1,580.4490
-929.4320
-58.3250
Tax Provision
-125.2150
-125.2150
-79.4070
0.6070
0
Net Income Common Stockholders
-1,672.2910
-1,672.2910
-1,501.0420
-930.0390
-58.3250
Diluted NI Available to Com Stockholders
-1,672.2910
-1,672.2910
-1,501.0420
-930.0390
-58.3250
Basic EPS
-0.02
-0.02
-0.02
-0.02
-0.00
Diluted EPS
-0.02
-0.02
-0.02
-0.02
-0.00
Basic Average Shares
103,182.2930
103,336.9370
94,654.0120
45,109.1960
20,340.0020
Diluted Average Shares
103,182.2930
103,336.9370
94,654.0120
45,109.1960
20,340.0020
Total Operating Income as Reported
-1,791.3600
-1,791.3600
-1,570.3080
-927.3220
-58.3250
Total Expenses
1,845.7620
1,845.7620
1,581.4280
751.6990
58.2180
Net Income from Continuing & Discontinued Operation
-1,672.2910
-1,672.2910
-1,501.0420
-930.0390
-58.3250
Normalized Income
-1,672.2910
-1,672.2910
-1,501.0420
-787.8135
-58.3250
Interest Income
0.0580
0.0580
0
--
--
Interest Expense
6.2040
6.2040
10.1410
2.1100
--
Net Interest Income
-9.5650
-9.5650
-11.9630
-2.1460
-0.1070
EBIT
-1,791.3020
-1,791.3020
-1,570.3080
-927.3220
-58.2180
EBITDA
-1,679.5420
-1,679.5420
-1,461.2350
-905.8000
-58.2180
Reconciled Cost of Revenue
84.4650
84.4650
71.3240
0
0
Reconciled Depreciation
111.7600
111.7600
109.0730
21.5220
0
Net Income from Continuing Operation Net Minority Interest
-1,672.2910
-1,672.2910
-1,501.0420
-930.0390
-58.3250
Total Unusual Items Excluding Goodwill
--
--
0
-175.5870
--
Total Unusual Items
--
--
0
-175.5870
--
Normalized EBITDA
-1,679.5420
-1,679.5420
-1,461.2350
-730.2130
-58.2180
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0002
0
Tax Effect of Unusual Items
0
0
0
-33.3615
0
9/30/2021 - 7/11/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BT3.BE Lineage Cell Therapeutics Inc
0.4060
+5.73%
 
22Z.SG Zealand Pharma A/S
56.18
-6.30%
 
25I.SG ImmuPharma PLC
0.0265
-10.17%
 
688428.SS InnoCare Pharma Limited
20.56
+0.54%
 
328.SG MeiraGTx Holdings PLC
4.7600
-0.83%
 
6XC.F Soleno Therapeutics, Inc.
64.85
+1.25%
 
688266.SS Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
99.49
+4.18%
 
CLAZF Claritas Pharmaceuticals, Inc.
0.0001
0.00%
 
688068.SS Beijing Hotgen Biotech Co., Ltd.
109.40
-0.18%
 
SCP.F Scancell Holdings plc
0.0825
-13.16%